Skip to main content
Caplight Logo









Artidis AG

Artidis AG

Private
BaselHealthcare & Life Scienceshttps://www.artidis.com/

Last Round

Seed

Dec 5, 2019

Total Funding Raised

$8.94M

Company Overview

Artidis AG is a Swiss health technology company developing a nanomechanical biomarker platform for cancer diagnosis and treatment optimization.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Healthcare Analytics, Biotechnology

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

nanomechanical biomarkercancer diagnosistissue stiffnessAI cancer diagnosisatomic force microscopyAFMprecision oncologyrapid diagnosticssolid tumor analysisbiopsy analysisnanomedicinedigital diagnosticsclinical decision supporthealth technologySaMD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Artidis AG Comparables

Compare Artidis AG with similar companies based on industry and business-model similarity.

Artidis AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellens Inc.
74%
Guardant Health
60%
X-ZELL
59%

Artidis AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 5, 2019

Key People

Founding team and executive leadership

Marija Plodinec

Chief Executive Officer

Executive Team

Dominique R. Leutwyler

Group CFO

Executive Team

Artidis AG Investors

Notable investors and investment history

Artidis AG investors
InvestorRounds
BERNINA BioInvest AGSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 822% MoM, from 426 to 3.9K.

  • Nov 9, 2025

    Monthly visitors grew 81% MoM, from 2.2K to 4K.

Artidis AG Filings

Explore SEC and related filing metadata, where available.

Artidis AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Artidis AG's valuation, stock price, and market status.

Is Artidis AG a public or private company?

Artidis AG is a private company.

What is the current stock price of Artidis AG?

Artidis AG is a private company with no public stock price. No recent secondary market data is available.

How much is Artidis AG worth (valuation)?

Valuation information for Artidis AG is not publicly available.

Can I buy Artidis AG stock?

Artidis AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Artidis AG's last funding round?

Artidis AG's most recent funding round was Seed on December 5, 2019.

Who are the main investors in Artidis AG?

Key investors in Artidis AG include BERNINA BioInvest AG.

Will Artidis AG IPO soon?

No public IPO plans have been announced for Artidis AG.

How can I track Artidis AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artidis AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range82
Year Founded2014
Last FundingDec 5, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?